Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 3
1967 1
1979 1
1980 1
1981 1
1984 2
1985 2
1986 2
1987 4
1988 4
1989 2
1990 3
1991 1
1993 1
1994 2
1995 2
1996 2
1997 3
1999 1
2000 1
2001 6
2002 4
2003 4
2004 11
2005 6
2006 6
2007 13
2008 10
2009 28
2010 23
2011 13
2012 5
2013 11
2014 10
2015 9
2016 18
2017 10
2018 22
2019 17
2020 17
2021 14
2022 19
2023 16

Text availability

Article attribute

Article type

Publication date

Search Results

312 results

Results by year

Filters applied: . Clear all
Page 1
Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non-Clear-Cell Renal Cell Carcinoma and Genomic Correlates.
Lee CH, Voss MH, Carlo MI, Chen YB, Zucker M, Knezevic A, Lefkowitz RA, Shapnik N, Dadoun C, Reznik E, Shah NJ, Owens CN, McHugh DJ, Aggen DH, Laccetti AL, Kotecha R, Feldman DR, Motzer RJ. Lee CH, et al. Among authors: knezevic a. J Clin Oncol. 2022 Jul 20;40(21):2333-2341. doi: 10.1200/JCO.21.01944. Epub 2022 Mar 17. J Clin Oncol. 2022. PMID: 35298296 Free PMC article. Clinical Trial.
TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma.
Erazo T, Evans CM, Zakheim D, Chu KL, Refermat AY, Asgari Z, Yang X, Da Silva Ferreira M, Mehta S, Russo MV, Knezevic A, Zhang XP, Chen Z, Fennell M, Garippa R, Seshan V, de Stanchina E, Barbash O, Batlevi CL, Leslie CS, Melnick AM, Younes A, Kharas MG. Erazo T, et al. Among authors: knezevic a. Nat Commun. 2022 Sep 27;13(1):5676. doi: 10.1038/s41467-022-33137-8. Nat Commun. 2022. PMID: 36167829 Free PMC article.
Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma.
Gleeson JP, Nikolovski I, Dinatale R, Zucker M, Knezevic A, Patil S, Ged Y, Kotecha RR, Shapnik N, Murray S, Russo P, Coleman J, Lee CH, Stadler ZK, Hakimi AA, Feldman DR, Motzer RJ, Reznik E, Voss MH, Chen YB, Carlo MI. Gleeson JP, et al. Among authors: knezevic a. Clin Cancer Res. 2021 May 15;27(10):2910-2919. doi: 10.1158/1078-0432.CCR-20-4367. Epub 2021 Mar 3. Clin Cancer Res. 2021. PMID: 33658299 Free PMC article.
Double tooth.
Knezević A, Travan S, Tarle Z, Sutalo J, Janković B, Ciglar I. Knezević A, et al. Coll Antropol. 2002 Dec;26(2):667-72. Coll Antropol. 2002. PMID: 12528297
Popović M, Knežević A, Dolinaj Škopelja J, Đolai M. Popović M, et al. Among authors: knezevic a. Acta Clin Croat. 2022 Aug;61(2):354-358. doi: 10.20471/acc.2022.61.02.23. Acta Clin Croat. 2022. PMID: 36818922 Free PMC article.
Progression-free Survival After Second Line of Therapy for Metastatic Clear Cell Renal Cell Carcinoma in Patients Treated with First-line Immunotherapy Combinations.
Fitzgerald KN, Duzgol C, Knezevic A, Shapnik N, Kotecha R, Aggen DH, Carlo MI, Shah NJ, Voss MH, Feldman DR, Motzer RJ, Lee CH. Fitzgerald KN, et al. Among authors: knezevic a. Eur Urol. 2023 Mar;83(3):195-199. doi: 10.1016/j.eururo.2022.10.017. Epub 2022 Nov 4. Eur Urol. 2023. PMID: 36344318
Angiomyoma--angioleiomyoma of the cheek.
Vidaković B, Knezević AK, Manojlović S, Knezević G. Vidaković B, et al. Among authors: knezevic ak. Coll Antropol. 2011 Mar;35(1):207-9. Coll Antropol. 2011. PMID: 21661373
[About suicide].
Knezević A. Knezević A. Med Pregl. 2009 Jan-Feb;62(1-2):5-6. Med Pregl. 2009. PMID: 19514592 Serbian. No abstract available.
312 results